BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 

Thursday, April 24, 2014
 
AstraZeneca PLC (AZN) To Shed Around 5,000 Jobs By 2016    More...

Celgene Corporation (CELG) Antes Up $710 Million Upfront For Phase 3-Ready Crohn's Disease Drug    More...

Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round    More...

Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round    More...

AstraZeneca PLC (AZN) Eyes Spin-Offs, Remains Mum On Pfizer Inc. (PFE)    More...

Hyperion Therapeutics Wagers Up To $570 Million On Andromeda Biotech To Beef Up Orphan Disease Pipeline    More...

Drugmaker Pharma Pac Lays Off Most Of Its Remaining Employees    More...

Alexion Pharmaceuticals Inc. (ALXN) CEO Racks Up $30 Million Salary In 2013    More...

 
More Breaking News



 
Novartis AG (NVS) Deal Makes GlaxoSmithKline (GSK)'s Pennsylvania Staffers Nervous    More...

Allergan Inc. (AGN) Curls Up Into Poison-Pill Position In Wake Of Valeant Pharmaceuticals International (VRX), Ackman Acquisition Bid    More...

After 23andMe, Inc.'s Setback, Another Silicon Valley Startup Hopes To Advance Genomics    More...

AstraZeneca PLC (AZN) Finally Rids Delaware Site For Approximately $44 Million    More...

Billionaire Outs Valeant Pharmaceuticals International (VRX) CEO As A Billionaire    More...

Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal    More...

How Big Pharma Holds Back In The War On Cancer    More...

Spectrum Pharmaceuticals, Inc. (SPPI)' s Cancer Drug Melphalan Meets Main Goal In Pivotal Trial    More...

With Big Pharma Failing, Ackman And Novartis AG (NVS) Try A New Blueprint For Drug Companies    More...

Puzzling Rare Birth Defects Hit Washington State    More...

 
More News

Did Chimerix, Inc. Set A Bad Example For Biopharma? </b>Did Chimerix, Inc. Set A Bad Example For Biopharma?

Chimerix generated some pretty negative publicity when it denied a dying seven-year old boy access to its experimental drug brincidofovir. Josh Hardy had developed an adenovirus infection following a bone marrow transplant related to past cancer treatment. Since Chimerix has a drug that has demonstrated some efficacy (albeit much of it anecdotal) in exactly this indication, doctors recommended the parents see about getting the medicine on a "compassionate use" basis. The company, however, demurred. More...
Executive Jobs
DepomedChief Medical Officer
CelgeneVice President, Global Medical Affairs
Novartis Institutes for BioMedical ResearchGlobal HR Partner, Executive Director
HospiraMedical Director, Biologics Medical Affairs

Search Jobs


Miles
Km80.5


 
Man Who Co-Discovered HIV Reveals Why There Won’t Be A Cure For AIDS    More...
Should And Would Amgen (AMGN) Break Itself Up?    More...
Hips Don't Lie: Women With Wide Hips More Likely To Have A One Night Stand, University of Leeds Study    More...
Antibiotic-Resistant MRSA "Superbug" Found In U.S. Homes, Columbia University Medical Center Study    More...
Antimicrobial Ingredient In Health Products Spurs Growth Of Breast Cancer Cells, American Chemical Society Reveals    More...
Gene Therapy Reverses Loss Of Memory In Mice With Alzheimer's, Universitat Autònoma de Barcelona Study    More...
Not Just For Sex: Why The Y Chromosome Is Essential For Male Survival, Whitehead Institute Study    More...
Money May Carry 3,000 Different Types Of Bacteria, New York University Reveals    More...
 
More Featured News


 

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.


Show me jobs for this employer
 
Feature Employer
 
Emerging Job Search Trends In 2014    More...

Hiring Managers Reveal The 15 BEST Words To Use On Your Resume    More...

10 Interview Questions; The Good, Bad, And The Ugly    More...

What Your Body Language Is Saying During The Interview    More...

The 2 Stages Of Job Search Rejection    More...

5 Resume Errors That Will Land You In The Trash    More...

5 Rules Of Employment Follow-Up    More...

3 Executive Resume Bloopers You’re Making Right Now    More...

3 Secrets To Interview-Winning Cover Letters    More...

6 Ways To Handle Irritating Colleagues    More...

 
More Career Tips



//-->